Knight Therapeutics Inc T.GUD

Alternate Symbol(s): KHTRF

Healthcare

Knight Therapeutics Inc. is a Canada-based specialty pharmaceutical company. The Company's principal business activity includes developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invested in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The Company's portfolio consists of pharmaceutical products with molecules and includes both in-licensed products, such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome as well as products owned (or partially owned) by it, such as Exelon and Impavido.

TSX:GUD - Post by User

Knight Therapeutics Inc > Bought back 196,000 shares

<< Previous

Bullboard Posts

Next >>

Comment by Catscratchon Jul 11, 2022 12:32pm

158 Views

Post# 34815427

RE:RE:RE:Bought back 196,000 shares

There are also been sizable insider buying over the past couple of years. A lot of stock is either getting bought/cancelled or landing in long term accounts (insiders, Armoyan, smart value funds etc.)

At some point the sellers aren't going to have any stock left and the share price should move higher.

<< Previous

Bullboard Posts

Next >>

Mid-year review: How has gold been performing?